Peptide ligand-mediated targeted drug delivery of nanomedicines

Biomaterials Science - Tập 7 Số 2 - Trang 461-471
Zhuxuan Jiang1,2,3,4,5, Juan Guan1,2,3,4,5, Jun Qian6,7,3,8,9, Changyou Zhan1,2,3,8,5
1Department of Pharmacology, School of Basic Medical Sciences & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200032, P.R. China
2Fudan University
3P. R. China
4School of Basic Medical Sciences & State Key Laboratory of Molecular Engineering of Polymers
5Shanghai 200032
6Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University)
7Ministry of Education
8School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, Shanghai 201203, P.R. China
9Shanghai 201203

Tóm tắt

Targeted drug delivery is emerging as a promising strategy to achieve better clinical outcomes.

Từ khóa


Tài liệu tham khảo

Matsumura, 1986, Cancer Res., 46, 6387

Sakurai, 2014, Expert Opin. Drug Delivery, 12, 41, 10.1517/17425247.2015.955847

Antignani, 2013, Toxins, 5, 1486, 10.3390/toxins5081486

Hasan, 2018, Curr. Clin. Pharmacol., 13, 236, 10.2174/1574884712666180802095521

Sapra, 2013, Pharmacol. Ther., 138, 452, 10.1016/j.pharmthera.2013.03.004

Maruyama, 1995, Biochim. Biophys. Acta, 1234, 74, 10.1016/0005-2736(94)00263-O

Paszko, 2012, Curr. Med. Chem., 19, 5239, 10.2174/092986712803833362

Drummond, 2008, J. Pharm. Sci., 97, 4696, 10.1002/jps.21358

Xiao, 2012, ACS Nano, 6, 3670, 10.1021/nn301869z

Li, 2013, J. Controlled Release, 171, 152, 10.1016/j.jconrel.2013.06.006

Mongelard, 2010, Curr. Opin. Mol. Ther., 12, 107

Bailey, 1999, J. Nutr., 129, 779, 10.1093/jn/129.4.779

Low, 2008, Acc. Chem. Res., 41, 120, 10.1021/ar7000815

Gabizon, 2003, Clin. Cancer Res., 9, 6551

Kue, 2016, Med. Res. Rev., 36, 494, 10.1002/med.21387

Leamon, 2003, Bioconjugate Chem., 14, 738, 10.1021/bc020089t

Liu, 2010, Biomaterials, 31, 330, 10.1016/j.biomaterials.2009.09.036

Bae, 2007, Biomacromolecules, 8, 650, 10.1021/bm0608939

Sapra, 2003, Prog. Lipid Res., 42, 439, 10.1016/S0163-7827(03)00032-8

Sikorski, 2014, Int. J. Nanomed., 1399

Oršolić, 2012, Cancer Metastasis Rev., 31, 173, 10.1007/s10555-011-9339-3

Arruda, 2015, Curr. Protein Pept. Sci., 16, 532, 10.2174/1389203716666150515125002

Bachran, 2016, Toxins, 8, 197, 10.3390/toxins8070197

Burgus, 1973, Proc. Natl. Acad. Sci. U. S. A., 70, 684, 10.1073/pnas.70.3.684

Pless, 1986, Scand. J. Gastroenterol., Suppl., 119, 54, 10.3109/00365528609087432

Patel, 1995, Life Sci., 57, 1249, 10.1016/0024-3205(95)02082-T

Hofsli, 2002, Tidsskr. Nor. Laegeforen., 122, 487

Vaidyanathan, 2007, Bioconjugate Chem., 18, 2122, 10.1021/bc700240r

Shen, 2008, Eur. J. Pharmacol., 601, 23, 10.1016/j.ejphar.2008.10.035

Sun, 2010, Nanotechnology, 21, 475101, 10.1088/0957-4484/21/47/475101

Li, 2016, Drug Delivery, 23, 3562, 10.1080/10717544.2016.1209797

Zhang, 2012, Biomaterials, 33, 679, 10.1016/j.biomaterials.2011.09.072

Erspamer, 1970, J. Pharm. Pharmacol., 22, 875, 10.1111/j.2042-7158.1970.tb08465.x

Märki, 1981, Peptides, 2, 169, 10.1016/0196-9781(81)90027-9

Accardo, 2012, J. Drug Targeting, 21, 240, 10.3109/1061186X.2012.741138

Kumar, 2007, Nature, 448, 39, 10.1038/nature05901

Pulford, 2010, PLoS One, 5, e11085, 10.1371/journal.pone.0011085

Conceição, 2016, Data Brief, 6, 700, 10.1016/j.dib.2016.01.017

Cook, 2015, J. Controlled Release, 220, 89, 10.1016/j.jconrel.2015.10.013

Kim, 2013, Biomaterials, 34, 1170, 10.1016/j.biomaterials.2012.09.047

Oswald, 2017, Mol. Pharmaceutics, 14, 2177, 10.1021/acs.molpharmaceut.7b00158

Lee, 2017, Adv. Mater., 29, 1605563, 10.1002/adma.201605563

Zhan, 2015, Adv. Drug Delivery Rev., 90, 101, 10.1016/j.addr.2015.04.025

Zhan, 2010, Mol. Pharmaceutics, 7, 1940, 10.1021/mp100238j

Nirthanan, 2002, J. Biol. Chem., 277, 17811, 10.1074/jbc.M111152200

Zhan, 2011, Angew. Chem., Int. Ed., 50, 5482, 10.1002/anie.201100875

Oller-Salvia, 2016, Angew. Chem., 128, 582, 10.1002/ange.201508445

Smith, 1985, Science, 228, 1315, 10.1126/science.4001944

Laakkonen, 2002, Nat. Med., 8, 751, 10.1038/nm720

Luo, 2010, Int. J. Pharm., 385, 150, 10.1016/j.ijpharm.2009.10.014

Uchida, 2011, ACS Nano, 5, 2493, 10.1021/nn102863y

Lo, 2008, Mol. Cancer Ther., 7, 579, 10.1158/1535-7163.MCT-07-2359

Ashley, 2011, Nat. Mater., 10, 389, 10.1038/nmat2992

Ashley, 2011, ACS Nano, 5, 5729, 10.1021/nn201397z

Medina, 2013, Adv. Healthcare Mater., 2, 1337, 10.1002/adhm.201200406

Binetruy-Tournaire, 2000, EMBO J., 19, 1525, 10.1093/emboj/19.7.1525

Niescioruk, 2017, J. Nanopart. Res., 19, 160, 10.1007/s11051-017-3859-x

Wang, 2018, J. Controlled Release, 284, 26, 10.1016/j.jconrel.2018.06.006

Ying, 2016, J. Controlled Release, 243, 86, 10.1016/j.jconrel.2016.09.035

Arap, 1998, Science, 279, 377, 10.1126/science.279.5349.377

Pasqualini, 2000, Cancer Res., 60, 722

Pastorino, 2006, Cancer Res., 66, 10073, 10.1158/0008-5472.CAN-06-2117

Garde, 2007, Anti-Cancer Drugs, 18, 1189, 10.1097/CAD.0b013e3282a213ce

Yang, 2014, Biomaterials, 35, 4368, 10.1016/j.biomaterials.2014.01.076

Lin, 2015, J. Drug Targeting, 24, 134, 10.3109/1061186X.2015.1058802

Yang, 2015, J. Pharm. Sci., 104, 1328, 10.1002/jps.24333

Pierschbacher, 1984, Nature, 309, 30, 10.1038/309030a0

Urtreger, 1997, Int. J. Oncol., 11, 489

Urtreger, 1999, Int. J. Cancer, 82, 748, 10.1002/(SICI)1097-0215(19990827)82:5<748::AID-IJC20>3.0.CO;2-R

Haubner, 1996, J. Am. Chem. Soc., 118, 7461, 10.1021/ja9603721

Nasongkla, 2004, Angew. Chem., Int. Ed., 43, 6323, 10.1002/anie.200460800

Zhan, 2010, J. Controlled Release, 143, 136, 10.1016/j.jconrel.2009.12.020

Graf, 2012, ACS Nano, 6, 4530, 10.1021/nn301148e

Sun, 2015, J. Biomed. Nanotechnol., 11, 1339, 10.1166/jbn.2015.2079

Shi, 2015, J. Controlled Release, 217, 138, 10.1016/j.jconrel.2015.09.009

Teesalu, 2009, Proc. Natl. Acad. Sci. U. S. A., 106, 16157, 10.1073/pnas.0908201106

Sugahara, 2009, Cancer Cell, 16, 510, 10.1016/j.ccr.2009.10.013

Marelli, 2013, Front. Oncol., 3, 222, 10.3389/fonc.2013.00222

Rejeeth, 2016, Artif. Cells, Nanomed., Biotechnol., 45, 489, 10.1080/21691401.2016.1175443

Ruoslahti, 2012, Adv. Mater., 24, 3747, 10.1002/adma.201200454

Lam, 1991, Nature, 354, 82, 10.1038/354082a0

Jia, 2017, Biomater. Sci., 5, 417, 10.1039/C6BM00898D

Qian, 2015, Methods Mol. Biol., 1248, 39, 10.1007/978-1-4939-2020-4_3

Liu, 2017, Adv. Drug Delivery Rev., 110–111, 13, 10.1016/j.addr.2016.05.009

Martinez-Ceron, 2016, Curr. Pharm. Biotechnol., 17, 449, 10.2174/1389201017666160114095553

Xiao, 2010, Mol. Cancer Ther., 9, 2714, 10.1158/1535-7163.MCT-10-0308

Wang, 2016, Mol. Cancer Ther., 15, 232, 10.1158/1535-7163.MCT-15-0544

Aina, 2005, Mol. Imaging, 4, 439, 10.2310/7290.2005.05169

Xiao, 2012, Cancer Res., 72, 2100, 10.1158/0008-5472.CAN-11-3883

Zhang, 2012, Urol. Oncol.: Semin. Orig. Invest., 30, 635, 10.1016/j.urolonc.2010.06.011

Pan, 2012, Int. J. Nanomed., 7, 2793, 10.2147/IJN.S27734

Pan, 2016, Nanotechnology, 27, 425103, 10.1088/0957-4484/27/42/425103

Geng, 2016, Theranostics, 6, 1261, 10.7150/thno.14302

Xu, 2003, J. Biomed. Biotechnol., 2003, 257, 10.1155/S1110724303209220

Zambaldo, 2015, Curr. Opin. Chem. Biol., 26, 8, 10.1016/j.cbpa.2015.01.005

Uttamchandani, 2006, Mol. BioSyst., 2, 58, 10.1039/B513935J

Schafmeister, 2000, J. Am. Chem. Soc., 122, 5891, 10.1021/ja000563a

Ruan, 2017, ACS Appl. Mater. Interfaces, 9, 17745, 10.1021/acsami.7b03682

Zhang, 2018, Mol. Pharmaceutics, 15, 430, 10.1021/acs.molpharmaceut.7b00801

Liu, 2016, Chem. Rec., 16, 1772, 10.1002/tcr.201600005

Goodman, 2002, Acc. Chem. Res., 12, 1, 10.1021/ar50133a001

Shao, 2010, J. Controlled Release, 147, 118, 10.1016/j.jconrel.2010.06.018

Xin, 2012, Biomaterials, 33, 1673, 10.1016/j.biomaterials.2011.11.018

Wei, 2014, Mol. Pharmaceutics, 11, 3261, 10.1021/mp500086e

Wei, 2015, Angew. Chem., Int. Ed., 54, 3023, 10.1002/anie.201411226

Prades, 2015, Angew. Chem., Int. Ed., 54, 3967, 10.1002/anie.201411408

Li, 2010, J. Biol. Chem., 285, 19572, 10.1074/jbc.M110.116814

Schumacher, 1996, Science, 271, 1854, 10.1126/science.271.5257.1854

Sun, 2012, J. Biotechnol., 161, 121, 10.1016/j.jbiotec.2012.05.019

Li, 2017, Bioconjugate Chem., 28, 2167, 10.1021/acs.bioconjchem.7b00326

Shannahan, 2015, Toxicol. Sci., 143, 136, 10.1093/toxsci/kfu217

Hulander, 2011, Int. J. Nanomed., 6, 2653, 10.2147/IJN.S24578

Bigdeli, 2016, ACS Nano, 10, 3723, 10.1021/acsnano.6b00261

Gheshlaghi, 2008, Acta Biochim. Biophys. Sin., 40, 777, 10.1093/abbs/40.9.777

Guan, 2018, Nat. Commun., 9, 2982, 10.1038/s41467-018-05384-1

Caracciolo, 2015, Nanomedicine, 11, 543, 10.1016/j.nano.2014.11.003

Karmali, 2011, Expert Opin. Drug Delivery, 8, 343, 10.1517/17425247.2011.554818

Hadjidemetriou, 2017, Nat. Nanotechnol., 12, 288, 10.1038/nnano.2017.61

Skubitz, 2017, Cancer Chemother. Pharmacol., 80, 787, 10.1007/s00280-017-3420-8

Tran, 2017, Clin. Transl. Med., 6, 44, 10.1186/s40169-017-0175-0

Y. Franco , T.Vaidya and S.Ait-Oudhia , Breast Cancer , Dove Med Press , 2018 , vol. 10 , pp. 131–141

Iwamoto, 2013, Biol. Pharm. Bull., 36, 715, 10.1248/bpb.b12-01102

Lotem, 2000, Arch. Dermatol., 136, 1475, 10.1001/archderm.136.12.1475

Lorusso, 2007, Ann. Oncol., 18, 1159, 10.1093/annonc/mdl477

Nakahara, 1996, J. Biol. Chem., 271, 27221, 10.1074/jbc.271.44.27221

Ren, 2014, Drug Delivery, 23, 1763, 10.3109/10717544.2015.1077293

Jin, 2016, Int. J. Pharm., 513, 138, 10.1016/j.ijpharm.2016.08.048

Bashari, 2017, Cancer Lett., 408, 164, 10.1016/j.canlet.2017.08.040

Eyvazi, 2017, Immunol. Lett., 190, 240, 10.1016/j.imlet.2017.08.028

Zhou, 2017, Eur. J. Pharm. Biopharm., 120, 80, 10.1016/j.ejpb.2017.08.011

Fukuta, 2017, Int. J. Pharm., 524, 364, 10.1016/j.ijpharm.2017.03.059

Tan, 2018, Anal. Bioanal. Chem., 410, 1071, 10.1007/s00216-017-0664-4

Bakhshinejad, 2018, Iran. J. Pharm. Res., 17, 396

Fogal, 2008, Cancer Res., 68, 7210, 10.1158/0008-5472.CAN-07-6752